Trial
NCT04181359
The Effect of Inhaled Nitric Oxide on Dyspnea and Exercise Tolerance in Interstitial Lung Disease.
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Alberta
Collaborators
—
Condition
Dyspnea
Intervention
Nitric Oxide
Why stopped
Study was no longer feasible as designed.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-09-19